Transcripts DocMorris AG OTC Markets

Stocks

ZRSEF

CH0042615283

Drug Retailers

Market Closed - OTC Markets 10:04:05 2025-12-26 EST			5-day change	1st Jan Change
7.454 ^USD	-27.18%		-.--%	-

08-21	DocMorris AG, H1 2026 Earnings Call, Aug 19, 2026
08-20	DocMorris AG : Gets a Buy rating from Deutsche Bank	ZD

Transcripts

08-21	DocMorris AG, H1 2026 Earnings Call, Aug 19, 2026
04-17	DocMorris AG, Q1 2026 Sales/ Trading Statement Call, Apr 16, 2026
03-24	DocMorris AG, 2025 Earnings Call, Mar 19, 2026
25-08-20	DocMorris AG, H1 2025 Earnings Call, Aug 19, 2025
25-04-10	DocMorris AG, Q1 2025 Sales/ Trading Statement Call, Apr 10, 2025
25-03-13	DocMorris AG, 2024 Earnings Call, Mar 13, 2025
24-08-20	DocMorris AG, H1 2024 Earnings Call, Aug 20, 2024
24-03-21	DocMorris AG, 2023 Earnings Call, Mar 21, 2024
23-08-17	Zur Rose Group AG, H1 2023 Earnings Call, Aug 17, 2023
23-03-23	Zur Rose Group AG, 2022 Earnings Call, Mar 23, 2023
22-08-18	Zur Rose Group AG, H1 2022 Earnings Call, Aug 18, 2022
22-03-24	Zur Rose Group AG, 2021 Earnings Call, Mar 24, 2022
21-10-21	Zur Rose Group AG Provides Revenue Guidance for the Year 2021	CI
21-08-18	Zur Rose Group AG, H1 2021 Earnings Call, Aug 18, 2021
21-08-18	Zur Rose Group AG Re-Affirm Earnings Guidance for the Year 2021	CI
21-06-16	Zur Rose Group AG - Analyst/Investor Day
21-03-18	Zur Rose Group AG, 2020 Earnings Call, Mar 18, 2021
21-03-18	Zur Rose Group AG Provides Earnings Guidance for the Year 2021	CI
20-10-21	Zur Rose Group AG Confirms Earnings Outlook for the Full Year 2020	CI
20-08-19	Zur Rose Group AG, H1 2020 Earnings Call, Aug 19, 2020
20-08-19	Zur Rose Group AG Provides Revenue Guidance for the Fiscal 2020	CI
20-07-16	Zur Rose Group AG Provides Consolidated Earnings Revenue Guidance for the First Half Ended June 30, 2020	CI
20-03-19	Zur Rose Group AG, 2019 Earnings Call, Mar 19, 2020
19-10-23	Zur Rose Group Ag Provides Earnings Guidance for the Full Year 2019; Provides Earnings Guidance for 2022	CI
19-04-17	Zur Rose Group Ag Announces Revenue Results for the First Quarter 2019; Reaffirms Guidance for the Group for 2019	CI